Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Chemical & Pharmaceutical Bulletin|April 1, 1991
Inhibition of avian myeloblastosis virus reverse transcriptase by heterocyclic quinones: structure-activity correlationY Inouye, H Matsumoto, R Morishige, et al.
The Journal of Antibiotics|October 1, 1992
A new anthracycline antibiotic, cinerubin R. Taxonomy, structural elucidation and biological activityM Nakata, M Saito, Y Inouye, et al.
Scientific Reports|March 5, 2020
Surface Enhanced Visible Absorption of Dye Molecules in the Near-Field of Gold NanoparticlesS Elhani, H Ishitobi, Y Inouye, et al.
Cancer|November 1, 1984
5'-Nucleotide phosphodiesterase isozyme-V as a marker for liver metastases in breast cancer patientsK C Tsou, R H Creech, W Y Inouye, et al.
Hiroshima Journal of Medical Sciences|September 1, 1994
Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycinY Inouye, M Hashimoto, M Sugiyama, et al.
Hiroshima Journal of Medical Sciences|December 1, 1991
Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agentsS Sowa, N Masumi, Y Inouye, et al.
The Journal of Antibiotics|February 1, 1989
A new group of antibiotics, hydroxamic acid antimycotic antibiotics. II. The structure of neoenactins NL1 and NL2 and structure-activity relationshipH Okada, K Yamamoto, S Tsutano, et al.
Bioscience, Biotechnology, and Biochemistry|March 1, 1992
Molecular cloning and expression of a Streptomyces sarcosine oxidase gene in Streptomyces lividansK Suzuki, M Ogishima, M Sugiyama, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1991
Antiviral activity of polyoxomolybdoeuropate PM-104 against human immunodeficiency virus type 1Y Inouye, Y Tokutake, T Yoshida, et al.
Hiroshima Journal of Medical Sciences|September 1, 1993
Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibioticsY Inouye, K Morifuji, N Masumi, et al.
Pageof 8